Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Someone is loading up 3M at $.0022 this morning. Maybe something big is on the way
Go $SIPC
$ADVT is number 3 on BOB. Bring lots of awareness now
Go $ADVT
$SIPC Sipp Industries Advanced Plasma Lights in Demand for Indoor Horticulture Applications
COSTA MESA, CA--(Marketwired - Feb 10, 2016) - Sipp Industries, Inc. (OTC: SIPC), a diversified conglomerate corporation specializing in technology, manufacturing and distribution of commercial and consumer products, today announces new sales and availability of advanced plasma lights for commercial and indoor growing applications.
Sipp Industries' plasma product line consists of two light models: H400 and H1000. These are equivalent to 400W metal halide or a 600W HPS and 1,000W metal halide or HPS. They are ideal lighting systems for indoor horticulture applications. With its optimized spectrum and energy efficiency, the lights have been shown to outperform both HPS and LEDs in terms of growth cycle, taste, smell and texture of the product while reducing energy costs up to 60%.
The demand for Sipp Industries advanced plasma lighting has been focused in the cannabis and medical marijuana sectors, but many applications such as lighting for parking lots, garages, and street are also ideal. The company is currently in business development talks with several indoor horticulture operations, as well as a large commercial lighting distributor.
"We have received excellent feedback from our initial Colorado-based growers. They have reported lower operating temperatures, decreased energy costs, as well as enhanced yield compared to their current HPS and LED lighting systems," stated Chief Executive Officer Syman Vong. "In addition, since plasma lighting is full-spectrum and closest semblance of sun light, there is no need for a bulb change during the growing cycle," continued Vong. "Due to the early successes, the majority of our new clients are direct referrals from our current clients. We expect sales to grow and will continue to ramp up inventory and sales efforts to meet demand."
About Sipp Industries, Inc.
Sipp Industries is a conglomerate corporation that specializes in technology, manufacturing and distribution of commercial and consumer products. For more information, please visit http://www.sippindustries.com. Facebook: https://www.facebook.com/SippIndustries Twitter: @SippIndustries
CONTACT INFORMATION
Contact
Syman Vong
CEO
Sipp Industries, Inc.
Investor Relations
949.220.0435
ir@sippindustries.com
www.sippindustries.com
$SIPC Sipp Industries Advanced Plasma Lights in Demand for Indoor Horticulture Applications
COSTA MESA, CA--(Marketwired - Feb 10, 2016) - Sipp Industries, Inc. (OTC: SIPC), a diversified conglomerate corporation specializing in technology, manufacturing and distribution of commercial and consumer products, today announces new sales and availability of advanced plasma lights for commercial and indoor growing applications.
Sipp Industries' plasma product line consists of two light models: H400 and H1000. These are equivalent to 400W metal halide or a 600W HPS and 1,000W metal halide or HPS. They are ideal lighting systems for indoor horticulture applications. With its optimized spectrum and energy efficiency, the lights have been shown to outperform both HPS and LEDs in terms of growth cycle, taste, smell and texture of the product while reducing energy costs up to 60%.
The demand for Sipp Industries advanced plasma lighting has been focused in the cannabis and medical marijuana sectors, but many applications such as lighting for parking lots, garages, and street are also ideal. The company is currently in business development talks with several indoor horticulture operations, as well as a large commercial lighting distributor.
"We have received excellent feedback from our initial Colorado-based growers. They have reported lower operating temperatures, decreased energy costs, as well as enhanced yield compared to their current HPS and LED lighting systems," stated Chief Executive Officer Syman Vong. "In addition, since plasma lighting is full-spectrum and closest semblance of sun light, there is no need for a bulb change during the growing cycle," continued Vong. "Due to the early successes, the majority of our new clients are direct referrals from our current clients. We expect sales to grow and will continue to ramp up inventory and sales efforts to meet demand."
About Sipp Industries, Inc.
Sipp Industries is a conglomerate corporation that specializes in technology, manufacturing and distribution of commercial and consumer products. For more information, please visit http://www.sippindustries.com. Facebook: https://www.facebook.com/SippIndustries Twitter: @SippIndustries
CONTACT INFORMATION
Contact
Syman Vong
CEO
Sipp Industries, Inc.
Investor Relations
949.220.0435
ir@sippindustries.com
www.sippindustries.com
$MJNA $MJNA Medical Marijuana Inc.’s CEO Delivers Historic Keynote Address on Cannabidiol (CBD) at VII Mexico City World Anti-Aging Congress
Feb 10, 2016
OTC Disclosure & News Service
-
SAN DIEGO, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that the Company’s Chief Executive Officer, Dr. Stuart W. Titus, will deliver a historic keynote address on cannabidiol (CBD) at the VII Mexico City World Anti-Aging Congress on February 13th.
The global healthcare conference takes place February 12th – 14th at the Hotel Fiesta Americana Reforma, Mexico City. Last week, Mexico’s government (COFEPRIS) issued the first permits for individuals to begin importation of CBD hemp oil (RSHO-X™) with a doctor’s recommendation. This global healthcare education event represents the first opportunity for the medical community to receive hands-on education about CBD directly from the Chief Executive Officer of Medical Marijuana, Inc.
“We are extremely honored to participate in the VII Mexico City World Anti-Aging Congress to educate the healthcare community in Mexico about CBD,” says Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “Our presentation will address the unique anti-aging properties of the hemp cannabis, research that supports cannabinoids as anti-oxidants and neuroprotectants, and why hemp is widely regarded as a ‘whole food’ and ‘superfood’ throughout the world.”
The VII Mexico City World Anti-aging Congress (Congreso Mundial en Medicina Antienvejecimiento AMA Mexico) event details are:
Congreso Mundial en Medicina Antienvejecimiento AMA Mexico
7th A4M Anti-Aging and Regenerative Medicine
Exhibit Space #19 – HempMeds® Mexico
12-14/02/2016
Puebla Privada Jalisco 8
Colonia El Carmen 7200
Tel: +56 80 65 68 or E-mail
www.medicina-antienvejecimiento.net
Venue: Hotel Fiesta Americana Reforma, Mexico City
For instructions on how to begin the RSHO-XTM import process, contact COFEPRIS for details. For information on RSHO-X™ product availability in Mexico, click here to register with HempMeds® Mexico website at http://www.hempmeds.mx. To speak with a HempMeds® Mexico representative, contact the customer service department at:
US: 1-866-786-2440
MX: 001-883-786-2440
Attention Members of the News Media:
Contact Andrew Hard to pre-register for a media pass to cover the historic keynote address and conduct interviews at the HempMeds® Mexico exhibit #19. Phone: 917.660.5418 or email to: Andrew.Hard@CMWMedia.com
About HempMeds® Mexico
HempMeds® Mexico is a Mexico-based company, created to provide access to cannabinoid-based products including cannabidiol (CBD) hemp oil products as they become legal in the country of Mexico for the first time. Our Company is a sales, marketing and distribution company. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to our CBD hemp oil products. HempMeds® Mexico is the first company to legally ship RSHO-XTM CBD hemp oil into Mexico. For more information, please review the company’s website at: http://hempmeds.mx/.
About HempMeds®
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
LEGAL DISCLOSURE
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
For further information, please contact:
Public Relations contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829-0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Primary Logo
Copyright © 2016 GlobeNewswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
$MJNA Medical Marijuana Inc.’s CEO Delivers Historic Keynote Address on Cannabidiol (CBD) at VII Mexico City World Anti-Aging Congress
Feb 10, 2016
OTC Disclosure & News Service
-
SAN DIEGO, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that the Company’s Chief Executive Officer, Dr. Stuart W. Titus, will deliver a historic keynote address on cannabidiol (CBD) at the VII Mexico City World Anti-Aging Congress on February 13th.
The global healthcare conference takes place February 12th – 14th at the Hotel Fiesta Americana Reforma, Mexico City. Last week, Mexico’s government (COFEPRIS) issued the first permits for individuals to begin importation of CBD hemp oil (RSHO-X™) with a doctor’s recommendation. This global healthcare education event represents the first opportunity for the medical community to receive hands-on education about CBD directly from the Chief Executive Officer of Medical Marijuana, Inc.
“We are extremely honored to participate in the VII Mexico City World Anti-Aging Congress to educate the healthcare community in Mexico about CBD,” says Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “Our presentation will address the unique anti-aging properties of the hemp cannabis, research that supports cannabinoids as anti-oxidants and neuroprotectants, and why hemp is widely regarded as a ‘whole food’ and ‘superfood’ throughout the world.”
The VII Mexico City World Anti-aging Congress (Congreso Mundial en Medicina Antienvejecimiento AMA Mexico) event details are:
Congreso Mundial en Medicina Antienvejecimiento AMA Mexico
7th A4M Anti-Aging and Regenerative Medicine
Exhibit Space #19 – HempMeds® Mexico
12-14/02/2016
Puebla Privada Jalisco 8
Colonia El Carmen 7200
Tel: +56 80 65 68 or E-mail
www.medicina-antienvejecimiento.net
Venue: Hotel Fiesta Americana Reforma, Mexico City
For instructions on how to begin the RSHO-XTM import process, contact COFEPRIS for details. For information on RSHO-X™ product availability in Mexico, click here to register with HempMeds® Mexico website at http://www.hempmeds.mx. To speak with a HempMeds® Mexico representative, contact the customer service department at:
US: 1-866-786-2440
MX: 001-883-786-2440
Attention Members of the News Media:
Contact Andrew Hard to pre-register for a media pass to cover the historic keynote address and conduct interviews at the HempMeds® Mexico exhibit #19. Phone: 917.660.5418 or email to: Andrew.Hard@CMWMedia.com
About HempMeds® Mexico
HempMeds® Mexico is a Mexico-based company, created to provide access to cannabinoid-based products including cannabidiol (CBD) hemp oil products as they become legal in the country of Mexico for the first time. Our Company is a sales, marketing and distribution company. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to our CBD hemp oil products. HempMeds® Mexico is the first company to legally ship RSHO-XTM CBD hemp oil into Mexico. For more information, please review the company’s website at: http://hempmeds.mx/.
About HempMeds®
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
LEGAL DISCLOSURE
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
For further information, please contact:
Public Relations contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 888-829-0070
andrew.hard@cmwmedia.com
www.cmwmedia.com
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com
www.facebook.com/mjnainc
Primary Logo
Copyright © 2016 GlobeNewswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
$PMCB nice news sir
PMCB Stonegate Capital Partners Publishes Research Report on PharmaCyte Biotech
http://www.otcmarkets.com/stock/PMCB/news/Stonegate-Capital-Partners-Publishes-Research-Report-on-PharmaCyte-Biotech?id=125008